• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Industrials·LBIRD.PA
Share

Lumibird SA Stocks

€ 27.25Last Updated 24.07.2026

Issuer Rating

3/7
Performance

Modest

Risk

Moderate

Recommendation

Sell

Market Cap

€ 682.69M

€ 27.25
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Lumibird SA specializes in the development, manufacturing, and commercialization of laser devices. Headquartered in Lannion, Bretagne, the company employs 541 dedicated full-time staff. Its extensive product offering includes various laser types such as compact pulsed and double-pulse Nd lasers, customizable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules, and powerful intense pulsed light instruments. Lumibird provides its advanced laser solutions to a broad spectrum of clients, spanning industrial, scientific, and medical sectors. The firm operates globally through key subsidiaries, including Quantel Medical, which focuses on diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, renowned for designing and producing fiber, glass, and tunable laser systems; and Quantel Derma AT, which concentrates on laser technology for dermatological and aesthetic applications.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA, ov

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of LBIRD.PA is 33.1 and suggests 21.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.07.2026 03:05

Amazon plans to deploy 5,000 satellites into orbit to compete with Starlink

28.07.2026 01:43

The S&P 500 and the Dow closed higher amid falling oil prices

27.07.2026 23:55

"Just Like a Nike Sneaker Drop": Ford Has Figured Out How to Boost Profits Through Customization

27.07.2026 23:27

Dior's owner reported an increase in sales of clothing and handbags for the first time in two years

27.07.2026 22:53

Nvidia formed an AI safety alliance following an accidental hack carried out by OpenAI

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026